AACR 2019: Tarloxotinib promising against NRG1-fusion cancers
Credit: University of Colorado Cancer Center A study by University of Colorado Cancer Center and Rain Therapeutics, Inc. presented at ...
Credit: University of Colorado Cancer Center A study by University of Colorado Cancer Center and Rain Therapeutics, Inc. presented at ...
Tobacco use causes a field of precancerous cells, increasing the risk of developing head & neck cancer. But exactly how ...
Credit: University of Colorado Cancer Center A cancer cell is like a racecar, speeding through the process of cellular replication. ...
Colorectal cancer is characterised by consistent changes in our gut bacteria across continents, cultures, and dietsCredit: EMBL in collaboration with ...
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver ...
Bottom Line: This study compared the risk of childhood cancer diagnosed in the first decade of life among children conceived ...
Credit: University of Colorado Cancer Center Many cancers are relatively harmless at their site of origin, and it is only ...
Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center found preliminary evidence that measuring byproducts of the hormone ...
ATLANTA -- A combination of the experimental histone deacetylase (HDAC) inhibitor entinostat with the anti-PD-1 therapeutic pembrolizumab (Keytruda) showed clinical ...
Credit: Cazaux et al., 2019 In a study that will be published April 1 in the Journal of Experimental Medicine, ...
New studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers explore biological mechanisms behind obesity and its ...
DC joins 37 states in passing Breast Density Screening and Notification Act to address little known risk factor for breast ...
ATLANTA -- Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia ...
ATLANTA -- Vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.